Distribution, type, and origin of Parkin mutations: review and case studies

Movement Disorders : Official Journal of the Movement Disorder Society
Katja HedrichPatricia Kramer

Abstract

Early-onset Parkinson's disease (PD) has been associated with different mutations in the Parkin gene (PARK2). To study distribution and type of Parkin mutations, we carried out a comprehensive literature review that demonstrated two prominent types of mutations among 379 unrelated mutation carriers: exon rearrangements involving exon 3, 4, or both, and alterations in exons 2 and 7, suggesting mutational hot spots or founders. To elucidate the origin of 14 recurrent Parkin mutations in our samples, we carried out a detailed haplotype analysis at the PARK2 locus. Thirty-eight mutation-positive individuals, available family members, and 62 mutation-negative individuals were genotyped. We determined allele frequencies and linkage disequilibrium (LD) to evaluate the significance of shared haplotypes. We observed no LD between markers at PARK2. Our data support a common founder for the most frequent Parkin point mutation (924C>T; exon 7) and indicate a mutational hot spot as cause of a common small deletion (255/256delA; exon 2). Furthermore, the most frequent Parkin exon deletion (Ex4del) arose independently in 2 of our subjects. However, it also occurred as the result of a founder mutation in 2 cases that shared identical deletion ...Continue Reading

References

Mar 1, 1992·Journal of Neurology, Neurosurgery, and Psychiatry·A J HughesA J Lees
Jun 1, 1988·Journal of Neurology, Neurosurgery, and Psychiatry·W R Gibb, A J Lees
Sep 10, 1998·Biochemical and Biophysical Research Communications·N HattoriY Mizuno
May 9, 2000·Human Heredity·J H ZhaoP C Sham
May 29, 2000·The New England Journal of Medicine·C B LückingUNKNOWN European Consortium on Genetic Susceptibility in Parkinson's Disease
Sep 29, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·S HayashiH Takahashi
Feb 17, 2001·American Journal of Human Genetics·M PeriquetUNKNOWN French Parkinson's Disease Genetics Study Group. The European Consortium on Genetic Susceptibility in Parkinson's Disease
Feb 24, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·H UjikeS Kuroda
Feb 24, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·C S LuY Mizuno
May 11, 2001·Nature·D E ReichE S Lander
Jun 19, 2001·Archives of Neurology·B S JeonY Mizuno
Jul 14, 2001·Science·J C StephensG F Vovis
Jul 19, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·Y KurodaT Matsumoto
Sep 18, 2001·Annals of Neurology·M FarrerJ W Langston
Jun 12, 2002·Archives of Neurology·Janet HoenickaJusto G de Yébenes
Jul 12, 2002·Nature·Elisabeth DawsonIan Dunham
Jul 12, 2002·Annals of Neurology·Martin KannChristine Klein
Jul 13, 2002·American Journal of Medical Genetics·Andrew WestUNKNOWN French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility on Parkinson's Disease
Oct 25, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·E MuñozR Oliva
Mar 5, 2003·Journal of the Neurological Sciences·Tomonori KobayashiNobutaka Hattori
Mar 12, 2003·Neurology·T ForoudUNKNOWN Parkinson Study Group
Apr 23, 2003·Neurology·N RawalUNKNOWN European Consortium on Genetic Susceptibility in Parkinson's Disease
Apr 30, 2003·Proceedings of the National Academy of Sciences of the United States of America·Rossano CesariCarlo M Croce
May 6, 2003·Annals of Neurology·Sofia A OliveiraJeffery M Vance
May 24, 2003·Brain : a Journal of Neurology·Magali PeriquetUNKNOWN European Consortium on Genetic Susceptibility in Parkinson's Disease
May 29, 2003·Neurology·S LincolnM Farrer
Jun 5, 2003·Parkinsonism & Related Disorders·Neziha Gouider-KhoujaFayçal Hentati
Jun 5, 2003·Parkinsonism & Related Disorders·R ChenP Chan
Jul 23, 2003·Archives of Neurology·Sofia A OliveiraEden R Martin

❮ Previous
Next ❯

Citations

Aug 16, 2008·Neurogenetics·Jung Mi ChoiYun Joong Kim
Dec 17, 2009·Neurogenetics·Rowena J KeyserSoraya Bardien
Jul 28, 2009·Expert Reviews in Molecular Medicine·Thomas Gasser
Aug 26, 2006·Nature Clinical Practice. Neurology·Christine Klein, Michael G Schlossmacher
Jun 23, 2005·European Journal of Human Genetics : EJHG·Christine KleinPeter P Pramstaller
Dec 20, 2007·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Nathan Pankratz, Tatiana Foroud
Apr 23, 2008·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Yoshikuni MizunoHideki Mochizuki
Feb 4, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M M WickremaratchiH R Morris
Aug 26, 2011·The Journal of Clinical Investigation·Kye-Young KimMichael N Sack
Oct 13, 2010·Journal of Geriatric Psychiatry and Neurology·Lynn M BekrisCyrus P Zabetian
Jul 21, 2009·Journal of Biomedical Science·Shyan-Yuan Kao
Sep 3, 2010·BMC Medical Genetics·Haiwang YangDacheng Tian
Mar 3, 2010·PloS One·W Edward C BradleyAbdelmajid Belouchi
Nov 19, 2013·PloS One·Alessandra ZanonIrene Pichler
Apr 29, 2009·International Journal of Molecular Sciences·Katrin BeyerAurelio Ariza
Sep 6, 2012·International Journal of Molecular Sciences·Hemant KumarDong-Kug Choi
Oct 1, 2012·Journal of Movement Disorders·Sang-Myung CheonJae Woo Kim
Nov 20, 2009·The International Journal of Neuroscience·Hasmet A HanagasiMurat Emre
Jun 15, 2011·The International Journal of Neuroscience·Miao CaiBao-rong Zhang
Aug 4, 2011·Journal of Chemical Neuroanatomy·David CrosiersChristine Van Broeckhoven
Nov 7, 2007·Journal of Neuropathology and Experimental Neurology·Katrin Beyer, Aurelio Ariza
Apr 3, 2015·Journal of Applied Genetics·Wojciech AmbroziakDorota Hoffman-Zacharska
Apr 12, 2016·Neurology. Genetics·Birgitt SchüleJ William Langston
Jul 19, 2015·Human Molecular Genetics·Johanna HuttenlocherKari Stefansson
Sep 1, 2009·Biochemical and Biophysical Research Communications·Shuichi AsakawaNobuyoshi Shimizu
Jul 28, 2016·Translational Neurodegeneration·Qingsong Hu, Guanghui Wang
Aug 5, 2015·Neuroscience Letters·Ji-Feng GuoBei-Sha Tang
Oct 27, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Denise M KayHaydeh Payami
Mar 21, 2006·Lancet Neurology·Anette Schrag, Jonathan M Schott
Jun 15, 2007·Expert Review of Neurotherapeutics·Michael R DouglasDavid J Nicholl
Apr 15, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Shin-ichiro KuboYoshikuni Mizuno
Dec 27, 2016·Brain Research Bulletin·Sandeep K BarodiaMatthew S Goldberg
Feb 16, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Farzaneh GhazaviElahe Elahi
Jun 23, 2011·The EMBO Journal·Viduth K ChauguleHelen Walden

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
C B LückingEuropean Consortium on Genetic Susceptibility in Parkinson's Disease
Annals of Neurology
E LohmannEuropean Consortium on Genetic Susceptibility in Parkinson's Disease
Movement Disorders : Official Journal of the Movement Disorder Society
Sarah J LincolnM Farrer
Brain : a Journal of Neurology
M PeriquetEuropean Consortium on Genetic Susceptibility in Parkinson's Disease
© 2021 Meta ULC. All rights reserved